Access Bio, Inc.
Registration 3024756665FEI 3024756665Monroe Township, NJ
Owner/operator: Access Bio, Inc.
- Manufacture Device in the United States for Export Only
- Manufacture Medical Device
Renewal due by December 31, 2026
Registered through 2026. Renew between October 1 and December 31, 2026, to stay registered for 2027.
90days left in the window
The 2026 window
- Oct 1Window opens91 days left
- Nov 3Where you stand58 days left
- Dec 1Our pay-by date30 days left
- Dec 15Two weeks left16 days left
- Dec 23Holiday week8 days left
- Dec 29Two days left2 days left
- Dec 31Window closes0 days left
- FDA fee, FY2027
- $13,785
- Our pay-by suggestion
- Dec 1
- Listed devices
- 10
- Added, last 12 months
- 3
FDA sets who pays the fee and who may qualify for a waiver; its fee page says so. The fee is paid only on FDA’s own fee site. Never through us. FDA’s fee page
The steps, in order
Pay FDA's annual feeYou
Order and pay the FY2027 establishment fee on FDA's Device Facility User Fee site. FDA emails you a PIN when you order.
FDA: registration and listing payment processWait for the payment confirmation numberYou
FDA emails a Payment Confirmation Number (PCN) once the payment processes, which FDA says typically takes several days. That is why we suggest paying by December 1.
FDA: registration and listing payment processRenew the registration in FDA's systemYou
Sign in to FDA's Unified Registration and Listing System (FURLS), complete the annual registration and apply your PIN and PCN. FDA does not count the registration as complete until both are applied.
FDA: device registration and listingReview every listingYou
In the same window, review each listing on file and report any changes, deletions and new listings. Your Listing Review Sheet puts every listing on one page.
FDA: device registration and listing
Every listed device 10
| Code | Device | Class | Regulation | Premarket |
|---|---|---|---|---|
| OSU | CareStart Dengue Combo NS1 & IgM/IgGDengue Serological Reagents | Class 2 | 21 CFR 866.3945 | — |
| JBF | CareStart G6PDGlucose-6-Phosphate Dehydrogenase (Erythrocytic), Screening | Class 2 | 21 CFR 864.7360 | — |
| SCA | CareSuperb COVID-19/Flu A&B Antigen Combo Home TestMulti-Analyte Respiratory Virus Antigen Detection Test | Class 2 | 21 CFR 866.3987 | K251604 |
| QYT | CareSuperb COVID-19 Antigen Home TestOver-The-Counter Covid-19 Antigen TestAdded Dec 24, 2025 | Class 2 | 21 CFR 866.3984 | K241915 |
| OAX | CareStart Malaria PAN (pLDH)Plasmodium Spp. Detection ReagentsAdded Dec 10, 2025 | Class 2 | 21 CFR 866.3402 | — |
| JJY | CareSuperb COVID-19/Flu A&B Antigen Combo External ControlMulti-Analyte Controls, All Kinds (Assayed)Added Jun 5, 2026 | Class 1 | 21 CFR 862.1660 | — |
| QKP | CareStart COVID-19 AntigenCoronavirus Antigen Detection Test System. | Not classified | — | — |
| QKO | CareStart COVID-19 Antibody External ControlsReagent, Coronavirus Serological | Not classified | — | — |
| QJR | CareStart COVID-19 MDx RT-PCRReagents, 2019-Novel Coronavirus Nucleic Acid | Not classified | — | — |
| QTU | CareSuperb Mpox (Monkeypox) Antigen Rapid TestReagents, Non-Variola Orthopoxvirus Or Monkeypox Virus Singleplex Antigen Tests | Not classified | — | — |
What changed
- Dec 24, 2025Listing added: QYT — CareSuperb COVID-19 Antigen Home Test (K241915)
- Dec 10, 2025Listing added: OAX — CareStart Malaria PAN (pLDH)
- Jun 5, 2026Listing added: JJY — CareSuperb COVID-19/Flu A&B Antigen Combo External Control